At Alcyone, we have developed a three-pronged approach to treating neurological disorders. We have engineered four platform technologies, across which there are several gene-based therapeutics. Each of our therapeutics is manufactured through our quality CMC process. Our novel precision delivery system Falcon™ optimizes administration to the patient.
X-Reactivation technology reactivates the silenced X chromosomes in X-linked genetic disorders, facilitating expression of the patient's own functional gene.
Alcyone has developed a customized approach to Chemistry, Manufacturing, and Controls, an integral part of pharmaceutical production that is particularly challenging for gene-based therapeutics.
Delivering therapeutics to the brain is a critical but challenging aspect of treating neurological conditions. The Falcon™ precision delivery technology utilizes computational algorithms to tailor drug delivery for each patient.
